Verona Pharma plc Verona Pharma Plc: Tr-1: Standard Form For Notification Of Major Holdings
July 27 2020 - 2:01AM
UK Regulatory
TIDMVRP
LONDON and RALEIGH, N.C., July 27, 2020 (GLOBE NEWSWIRE) --
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the
relevant issuer and to the FCA in Microsoft Word format
if possible)(i)
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
1a. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are attached(ii)
: Verona Pharma plc
------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer
(please mark with an "X" if appropriate)
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Non-UK issuer
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------
2. Reason for the notification (please mark the appropriate
box or boxes with an "X")
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------
An acquisition or disposal of financial instruments
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------
An event changing the breakdown of voting rights
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------
Other (please specify)(iii) :
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------
3. Details of person subject to the notification obligation(iv)
Name Novo Holdings A/S
City and country of registered office (if applicable)
4. Full name of shareholder(s) (if different from
3.)(v)
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Name
------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------
City and country of registered office (if applicable)
------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------
5. Date on which the threshold was crossed or reached(vi)
: July 22, 2020
------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------
6. Date on which issuer notified (DD/MM/YYYY): July 22, 2020
------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------
7. Total positions of person(s) subject to the notification
obligation
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
% of voting rights attached to shares (total of 8. % of voting rights through financial instruments Total of both in
A) (total of 8.B 1 + 8.B 2) % (8.A + 8.B) Total number of voting rights of issuer(vii)
--------------------------------------------------- -------------------------------------------------- ------------------------------------------------ ---------------- --------------------------------------------
Resulting situation on the date on which threshold
was crossed or reached 5.1364% 5.1364% 414,278,294
--------------------------------------------------- -------------------------------------------------- ------------------------------------------------ ---------------- --------------------------------------------
Position of previous notification (if
applicable)
--------------------------------------------------- -------------------------------------------------- ------------------------------------------------ ---------------- --------------------------------------------
8. Notified details of the resulting situation on
the date on which the threshold was crossed or reached(viii)
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Class/type of
shares
ISIN code (if possible) Number of voting rights(ix) % of voting rights
--------------------------
Direct Indirect Direct Indirect (Art 10 of Directive 2004/109/EC)
(Art 9 of Directive 2004/109/EC) (DTR5.1) (Art 10 of Directive 2004/109/EC) (DTR5.2.1) (Art 9 of Directive 2004/109/EC) (DTR5.1) (DTR5.2.1)
------------------------- ------------------------------------------ --------------------------------------------- ----------------------------------------------------- ---------------------------------------------
Ordinary Shares (0.1p)
GB00B06GSH43 6,464,065 1.5603%
-------------------------- ------------------------------------------ --------------------------------------------- ------------------------------ ---------------------------------------------
ADSs
US9250501064 14,814,808 3.5761%
-------------------------- ------------------------------------------ --------------------------------------------- --------------------- ------------------------------ ---------------------------------------------
SUBTOTAL 8. A 21,278,873 5.1364%
-------------------------- ----------------------------------------------------------------------------------------- ----------------------------------------------------- ---------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a)
of Directive 2004/109/EC (DTR5.3.1.1 (a))
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting rights that may be acquired if the % of voting rights
instrument date(x) Conversion Period(xi) instrument is exercised/converted.
-------------------------- ------------------------------------------ --------------------------------------------- ----------------------------------------------------- ---------------------------------------------
SUBTOTAL 8. B 1
--------------------------------------------- ----------------------------------------------------- ---------------------------------------------
B 2: Financial Instruments with similar economic effect
according to Art. 13(1)(b) of Directive 2004/109/EC
(DTR5.3.1.1 (b))
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Conversion Physical or cash Number of voting rights % of voting rights
instrument date(x) Period (xi) settlement(xii)
------------------------- ------------------------------------------- --------------------------------------------- --------------------- ------------------------------ ---------------------------------------------
SUBTOTAL 8.B.2
--------------------- ------------------------------ ---------------------------------------------
9. Information in relation to the person subject to
the notification obligation (please mark the applicable
box with an "X")
Person subject to the notification obligation is not X
controlled by any natural person or legal entity and
does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying)
issuer(xiii)
Full chain of controlled undertakings through which
the voting rights and/or the financial instruments
are effectively held starting with the ultimate controlling
natural person or legal entity(xiv) (please add additional
rows as necessary)
-------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------
Name(xv) % of voting rights if it equals or is higher than % of voting rights through financial instruments if Total of both if it equals or is higher than the notifiable
the notifiable threshold it equals or is higher than the notifiable threshold threshold
-------- ------------------------------------------------- ----------------------------------------------------- -------------------------------------------------------------
10. In case of proxy voting, please identify:
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Name of the proxy holder
----------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------
The number and % of voting rights held
----------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------
The date until which the voting rights will be held
----------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------
11. Additional information(xvi)
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Place of completion Outside a trading venue
------------------- -----------------------
Date of completion 22 July 2020
------------------- -----------------------
For further information, please contact:
Verona Pharma plc Tel: +44 (0)20 3283 4200
David Zaccardelli, Chief Executive Officer info@veronapharma.com
Victoria Stewart, Director of Communications
N+1 Singer (Nominated Adviser and UK Broker) Tel: +44 (0)20 7496 3000
Aubrey Powell / George Tzimas / Iqra Amin (Corporate
Finance)
Tom Salvesen (Corporate Broking)
(END) Dow Jones Newswires
July 27, 2020 02:01 ET (06:01 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jul 2023 to Jul 2024
